Trademark: 87158910
Word
CHOLESTOSOME
Status
Dead
Status Code
606
Status Date
Monday, October 29, 2018
Serial Number
87158910
Mark Type
4000
Filing Date
Thursday, September 1, 2016
Published for Opposition
Tuesday, January 31, 2017
Abandoned Date
Monday, October 29, 2018

Trademark Owner History
TheraHoldings AG - Owner At Publication

Classifications
5 Pharmaceutical preparations for Alzheimer's disease, Parkinson's disease, bacterial infections, viral infections, fungal infections, sepsis, psoriasis, sunburn and thermal injury to skin and underlying tissues, lung, asthma, chronic obstructive pulmonary disease (COPD), emphysema, cancer of any or all types, diabetes, hepatic diseases including hepatitis b or c, hepatic disease including non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), metabolic syndrome diseases, genetic disorders, Fabry's disease, alpha 1 anti-trypsin deficiency, hemophilia, cystic fibrosis, and cancers of all types, systemic inflammatory diseases including inflammatory bowel diseases, Crohn's disease, rheumatoid arthritis, Systemic lupus erythematosus (SLE), ankylosing spondylitis and vaccines and vaccination to prevent or treat infectious diseases and cancer; pharmaceutical preparations, namely, lipid vesicles encapsulating pharmaceuticals for the treatment of Alzheimer's disease, Parkinson's disease, bacterial infections, viral infections, fungal infections, sepsis, psoriasis, sunburn and thermal injury to skin and underlying tissues, lung, asthma, chronic obstructive pulmonary disease (COPD), emphysema, cancer of any or all types, diabetes, hepatic diseases including hepatitis b or c, hepatic disease including non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), metabolic syndrome diseases, genetic disorders, Fabry's disease, alpha 1 anti-trypsin deficiency, hemophilia, cystic fibrosis, and cancers of all types, systemic inflammatory diseases including inflammatory bowel diseases, Crohn's disease, rheumatoid arthritis, Systemic lupus erythematosus (SLE), ankylosing spondylitis and vaccines and vaccination to prevent or treat infectious diseases and cancer; pharmaceutical preparations, namely, vesicles made of cholesteryl ester and containing pharmaceuticals for use in the treatment of Alzheimer's disease, Parkinson's disease, bacterial infections, viral infections, fungal infections, sepsis, psoriasis, sunburn and thermal injury to skin and underlying tissues, lung, asthma, chronic obstructive pulmonary disease (COPD), emphysema, cancer of any or all types, diabetes, hepatic diseases including hepatitis b or c, hepatic disease including non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), metabolic syndrome diseases, genetic disorders, Fabry's disease, alpha 1 anti-trypsin deficiency, hemophilia, cystic fibrosis, and cancers of all types, systemic inflammatory diseases including inflammatory bowel diseases, Crohn's disease, rheumatoid arthritis, Systemic lupus erythematosus (SLE), ankylosing spondylitis, and vaccines and vaccination to prevent or treat infectious diseases and cancer

Trademark Events
Oct 29, 2018
Abandonment Notice Mailed - No Use Statement Filed
Oct 29, 2018
Abandonment - No Use Statement Filed
Mar 20, 2018
Notice Of Approval Of Extension Request E-Mailed
Mar 16, 2018
Extension 2 Granted
Mar 16, 2018
Extension 2 Filed
Mar 16, 2018
Teas Extension Received
Sep 5, 2017
Notice Of Approval Of Extension Request E-Mailed
Sep 1, 2017
Extension 1 Granted
Sep 1, 2017
Extension 1 Filed
Sep 1, 2017
Teas Extension Received
May 1, 2017
Assigned To Examiner
Mar 28, 2017
Noa E-Mailed - Sou Required From Applicant
Jan 31, 2017
Official Gazette Publication Confirmation E-Mailed
Jan 31, 2017
Published For Opposition
Jan 11, 2017
Notification Of Notice Of Publication E-Mailed
Dec 19, 2016
Approved For Pub - Principal Register
Dec 14, 2016
Examiner's Amendment Entered
Dec 14, 2016
Notification Of Examiners Amendment E-Mailed
Dec 14, 2016
Examiners Amendment E-Mailed
Dec 14, 2016
Examiners Amendment -Written
Dec 10, 2016
Assigned To Examiner
Sep 8, 2016
New Application Office Supplied Data Entered In Tram
Sep 5, 2016
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24